The estimated Net Worth of Taiyin Yang is at least $6.42 million dollars as of 21 February 2007. Taiyin Yang owns over 20,000 units of Kodiak Sciences Inc stock worth over $410,961 and over the last 20 years he sold KOD stock worth over $5,602,200. In addition, he makes $402,014 as Independent Director at Kodiak Sciences Inc.
Taiyin has made over 6 trades of the Kodiak Sciences Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently he sold 20,000 units of KOD stock worth $1,474,400 on 21 February 2007.
The largest trade he's ever made was exercising 99,046 units of Kodiak Sciences Inc stock on 13 February 2006 worth over $528,906. On average, Taiyin trades about 8,593 units every 37 days since 2004. As of 21 February 2007 he still owns at least 166,381 units of Kodiak Sciences Inc stock.
You can see the complete history of Taiyin Yang stock trades at the bottom of the page.
Dr. Taiyin Yang serves as Independent Director of the Company. r. Yang joined Gilead Science, Inc., a research-based biopharmaceutical company, in 1993 and was appointed to her current role as Executive Vice President, Pharmaceutical Development and Manufacturing in January 2015. Prior to joining Gilead, Dr. Yang was Director of Analytical Chemistry at Syntex Corporation, a pharmaceutical company. She received her bachelor’s degree in Chemistry from National Taiwan University and her Ph.D. in Organic Chemistry from the University of Southern California.
As the Independent Director of Kodiak Sciences Inc, the total compensation of Taiyin Yang at Kodiak Sciences Inc is $402,014. There are 6 executives at Kodiak Sciences Inc getting paid more, with Victor Perlroth having the highest compensation of $17,642,000.
Taiyin Yang is 66, he's been the Independent Director of Kodiak Sciences Inc since 2019. There are 1 older and 11 younger executives at Kodiak Sciences Inc. The oldest executive at Kodiak Sciences Inc is Robert Profusek, 70, who is the Lead Independent Director.
Taiyin's mailing address filed with the SEC is 1200 PAGE MILL ROAD, , PALO ALTO, CA, 94304.
Over the last 6 years, insiders at Kodiak Sciences Inc have traded over $15,919,920 worth of Kodiak Sciences Inc stock and bought 10,439,459 units worth $472,964,631 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., Bros. Advisors Lp667, L.P.B... et Victor Perlroth. On average, Kodiak Sciences Inc executives and independent directors trade stock every 27 days with the average trade being worth of $393,170. The most recent stock trade was executed by John A. Borgeson on 15 June 2024, trading 5,494 units of KOD stock currently worth $13,570.
about kodiak kodiak is a high-science retinal medicines development company. we are aspiring to build a dominant global retina franchise. we are developing a top pipeline of proprietary best-in-class medicines for the treatment of patients with age-related macular degeneration and diabetic eye disease, two leading causes of blindness. our science begins with an antibody biopolymer product platform merging the fields of biologics and chemistry based therapies. in our medicines we aim to restore vision, to stop progression of underlying disease, and to require fewer treatments. working at kodiak we are passionate about preventing blindness and improving health. we take pride in scientific and operational excellence. the curiosity, creativity, and courage of our team members drives our progress. we highly value this culture and support it every way we can. kodiak supports a vibrant and active lifestyle. we have a top benefits package. we are within walking distance to california avenue sh
Kodiak Sciences Inc executives and other stock owners filed with the SEC include: